Reduction of HIV-1 drug resistance after intrapartum single-dose nevirapine
- PMID: 17997152
- DOI: 10.1016/S0140-6736(07)61606-7
Reduction of HIV-1 drug resistance after intrapartum single-dose nevirapine
Erratum in
- Lancet. 2008 Feb 23;371(9613):650
Comment on
-
Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial.Lancet. 2007 Nov 17;370(9600):1698-705. doi: 10.1016/S0140-6736(07)61605-5. Epub 2007 Nov 7. Lancet. 2007. PMID: 17997151 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
